The safety and efficacy of combination yv-butyl-deoxynojirimycin (Sc-48334) and zidovudine in patients with hiv-1 infection and 200-500 cd4 cells/mm3

Margaret A. Fischl, Lionel Resnick, Robert Coombs, Alton B. Kremer, John C. Pottage, Robert J. Fass, Kenneth H. Fife, William G. Powderly, Ann C. Collier, Richard L. Aspinall, Susan L. Smith, Kenneth G. Kowalski, Carl Bertil Wallemark

Research output: Contribution to journalArticlepeer-review

118 Scopus citations
Original languageEnglish
Pages (from-to)139-147
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Issue number2
StatePublished - Feb 1994


  • Combination therapy
  • Glucosidase inhibitor
  • Hiv
  • N-butyl-deoxynojirimvein (sc-48334)

Cite this